Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Comparative Effects of Aerobic Exercises and Jacobson's Progressive Relaxation Technique in Primary Dysmenorrhea

1 de junio de 2026 actualizado por: Riphah International University

Comparative Effects of Aerobic Exercises and Jacobson's Progressive Relaxation Technique on Pain, Fatigue and Quality of Life in Primary Dysmenorrhea

The study will focus on the comparative effects of aerobic exercises and Jacobson's progressive relaxation technique on pain, fatigue and quality of life in primary dysmenorrhea.

This study will be a randomized clinical trial and will be conducted in, Superior college depalpur and Army public schools and college Lahore (APSACS). Non probability convenience sampling will be used to collect the data.64 participants will be selected on the basis of inclusion and exclusion criteria and will be equally divided into two groups by sealed opaque enveloped .Participants having age group between 17-24 years and diagnosed with WaLiDD score are included.

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Intervención / Tratamiento

Descripción detallada

Primary dysmenorrhea (PD) refers to menstrual pain without organic lesions in the pelvic cavity , which mainly manifests as spastic pain and distension above the symphysis pubis in the lower abdomen before and after or during menstruation, radiating to the lumbosacral region and inner thigh. PD is a common gynecological disorder affecting 50%-90% of women. The study will focus on the comparative effects of aerobic exercises and Jacobson's progressive relaxation technique on pain, fatigue and quality of life in primary dysmenorrhea.

This study will be a randomized clinical trial and will be conducted in, Superior college depalpur and Army public schools and college Lahore (APSACS). Non probability convenience sampling will be used to collect the data.64 participants will be selected on the basis of inclusion and exclusion criteria and will be equally divided into two groups by sealed opaque enveloped .Participants having age group between 17-24 years and diagnosed with WaLiDD score are included. Athletes and married women will be excluded. Outcome measures will be taken using Numeric pain rating scale (NPRS) for pain, EQ-5D-5L questionnaire for quality of life, fatigue assessment scale for fatigue. Both Groups will receive same baseline treatment which is core muscle strength. Group A will receive aerobic exercises and Group B will receive Jacobson's progressive relaxation technique for 3 times in a week. The treatment will be given for 8 weeks. Outcome measures will be measured at baseline and after 8 weeks. Data analysis will be done by SPSS version 25.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

58

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • Punjab Province
      • Okāra, Punjab Province, Pakistán, 52513
        • Reclutamiento
        • Superior college for women and Polytechnic institute
        • Investigador principal:
          • Aansa Manzoor, MSWHPT

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Pain on numeric rating pain scale,
  • Menarche range 12-16,
  • BMI less than 30,
  • Having a regular menstrual cycle (28-32) days,
  • Normal bleeding days (3 to 1) and diagnosed with mild PD according to WaLiDD score

Exclusion Criteria:

  • Athletes,
  • married women with gynaecological abnormalities were excluded,
  • Medical treatment during the study (e.g., oral contraceptives, antidepressants)
  • Recent musculoskeletal trauma or surgery, or chronic musculoskeletal disorders
  • affecting pain perception (e.g., fibromyalgia, pelvic floor dysfunction)
  • secondary dysmenorrhea-related conditions (e.g., endometriosis, fibroids, ovarian cysts),
  • consumption of painkillers
  • No mental or physical diseases, which reduce the abilities to exercise

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Comparador activo: aerobic exercises
Group A will receive aerobic exercises for 3 times in a week.

Group A Duration of forty five minutes Warm up exercises for 10 minutes. Free active movement of upper limb, lower limb, and upper body, cross toe to touch dynamic stretches such as lunges, Achilles tendon and hamstrings stretching. The aerobic workout duration will be 25mins.. The aerobic exercise involved the following steps with15reps of each exercise and while changing the step slow marching step for 15second and then move towards the next step.

single step touch, double step touch, step touch front and back ,grapevine, knee lift , lunge side and back, L step ,V step, jumping jacks. Cool down exercises for 10 minutes included slow marching, quadriceps and hamstring and stretching. Subjects were prohibited from aerobics during menstruation and data were recorded for two menstrual cycles.

Experimental: Jacobson's progressive relaxation technique
Group B will receive Jacobson's progressive relaxation technique for 3 times in a week.
Group B Jacobson's relaxation technique is a type of therapy that focuses on tightening and relaxing specific muscle groups in a sequence that makes you feel calmer and makes you aware of your body and physical sensations. It is also known as PMRT. (39) JPRT was applied three times a week from the estimated date of ovulation to the onset of the next menstruation. . The participants were in a supine position and were supported with cushions. The JPRT involves participants actively contracting muscles to create tension and then progressively releasing them. First of all, the participants were asked to contract the muscles tightly and hold for slow count of 5seconds (s) and then relax them completely for 10 s. At the same time, the participants practiced diaphragmatic breathing. The participants repeatedly performed JPMRT for each body part. Each session lasted about 20-30 min.
Otros nombres:
  • Aerobic exercises and hypopressive

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
WaLlDD relaxation technique on pain, fatigue and quality of life in primary dysmenorrhea.
Periodo de tiempo: 2 months
At baseline, the participant scored at the initial level on the WaLliDD scale, indicating their starting status. Over time, changes in the score reflect improvement or decline in the measured outcome. An increase in score suggests positive progress in the targeted domain, while a decrease indicates reduced functioning or worsening condition compared to baseline.
2 months
Fatigue Assessment Scale
Periodo de tiempo: 2 months
At baseline, the participant's fatigue level is measured using the Fatigue Assessment Scale, providing a starting score of perceived fatigue. Changes in the score over time indicate variation in fatigue severity. A decrease from baseline reflects improvement (reduced fatigue), while an increase indicates worsening fatigue compared to the initial assessment.
2 months
EQ-5D-5-L-Questionnaire
Periodo de tiempo: 2 months
The EQ-5D-5L is a standardized questionnaire used to assess health-related quality of life. It measures five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each rated on five levels of severity. It also includes a visual analog scale (VAS) where individuals rate their overall health. Higher scores indicate better perceived health status.
2 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Hafiza Iqra Rubab, MSWHPT, Riphah International University

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de octubre de 2025

Finalización primaria (Estimado)

1 de julio de 2026

Finalización del estudio (Estimado)

1 de julio de 2026

Fechas de registro del estudio

Enviado por primera vez

1 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

1 de junio de 2026

Publicado por primera vez (Actual)

5 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

5 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

1 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • REC/RCR&AHS/25/0514

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .